Iron Dextran and Injectable Iron in Canada: Top 5 Options for 2026
Published on Tuesday, January 27, 2026
Iron dextran refers to a class of injectable iron treatments used to correct moderate to severe iron deficiency anemia when oral iron is not tolerated, not effective, or when rapid repletion is needed. In Canada these products are used in hospital and clinic settings for patients with chronic kidney disease, inflammatory bowel disease, heavy menstrual bleeding, postpartum anemia, or preoperative anemia protocols. Consumers and clinicians in Canada favor injectable iron for its faster restoration of hemoglobin and iron stores, lower incidence of gastrointestinal side effects compared with oral iron, and convenient dosing options that can reduce the need for repeated daily pills. Key decision factors in Canadian markets include safety profile, provincial formulary coverage, single-visit dosing versus multiple infusions, product availability, and local clinician experience. This category page highlights what to know about iron dextran and related intravenous iron products, and how Canadians typically choose between brands such as Dexiron, Infufer, CosmoFer, INFeD, and Ferrlecit.
Top Picks Summary
Dexiron
Dexiron is positioned as a cost-conscious iron dextran option, often selected by hospitals and clinics seeking a lower-priced generic alternative to established brands. It competes on price and basic efficacy with branded dextran products like CosmoFer and INFeD, though buyers should consider potential variability in manufacturing and supply chain quality versus long-standing market leaders.
What the Research Says: Benefits and Safety of Injectable Iron
Clinical research and international guidelines support the use of intravenous iron for specific patient groups who need more rapid or reliable iron repletion than oral therapy can provide. Randomized trials and meta-analyses have shown that IV iron produces faster increases in hemoglobin and ferritin compared with oral iron, reduces the need for blood transfusion in surgical and obstetric settings, and improves fatigue and quality of life measures in many patients. Safety data emphasize that most modern IV iron formulations have low rates of serious allergic reactions when administered correctly, though rare hypersensitivity can occur. Older high molecular weight iron dextran products were associated with higher anaphylaxis risk, which led to practice changes and broader use of low molecular weight dextran or non-dextran formulations with improved tolerability. Health care providers follow evidence-based monitoring and infusion protocols to minimize risk and select the formulation best suited to the patient and clinical setting.
IV iron restores hemoglobin and iron stores more quickly than oral iron in many patients.
Studies show IV iron can reduce transfusion needs in preoperative and obstetric care.
Modern formulations have a low incidence of severe allergic reactions when administered under supervision.
Older high molecular weight iron dextran had higher anaphylaxis risk; this influenced product choice and monitoring practices.
Clinical guidelines recommend IV iron for patients who do not respond to or cannot tolerate oral iron, and for some chronic conditions such as CKD and inflammatory bowel disease.
Frequently Asked Questions
Which option should I pick for rapid repletion?
If you want outpatient rapid repletion with fewer visits, consider Infufer; it’s a ferric carboxymaltose-style IV iron designed to deliver large single doses per infusion, with an average rating of 4.4.
How is CosmoFer different from older iron dextran?
CosmoFer is low‑molecular‑weight iron dextran intended to reduce the risk of severe hypersensitivity versus older formulations, with an average rating of 4.5.
Does Dexiron cost less than CosmoFer for IV iron?
The provided data does not include prices for Dexiron or CosmoFer, so I can’t compare cost; what we do have is Dexiron’s average rating of 4.2 and CosmoFer’s 4.5.
Does Dexiron require a test dose during infusion?
Dexiron may require a test dose and monitored administration due to hypersensitivity reaction risk, and its average rating is 4.2.
Conclusion
In Canada the injectable iron category includes a range of options — Dexiron, Infufer, CosmoFer, INFeD, and Ferrlecit — each with different dosing schedules, formulation histories, and local availability. For many Canadian patients and clinics, CosmoFer (iron sucrose) is often considered the best overall choice among these five due to its established safety and predictable dosing profile, but individual needs, provincial formularies, and clinician preference will affect the final selection. We hope this guide helped you understand injectable iron options and find what you were looking for. You can refine or expand your search using the search to compare dosing, safety notes, provincial coverage, and clinic availability.